USPTO serial 97649648
STARBRIGHT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 6, 2026
- Examiner
- HACK,ANDREA R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with STARBRIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Margaret C. McHugh
Margaret C. McHugh KILPATRICK TOWNSEND & STOCKTON LLPTWO EMBARCADERO CENTER, SUITE 1900SAN FRANCISCO, CA 94111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Fluorescent dyes for scientific or research use; fluorescent dyes for scientific use in life science applications; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for scientific, laboratory, or research purposes; fluorescent dyes for research use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; proteins for scientific and research use; cell culture proteins for scientific and research use; biochemical, namely, monoclonal antibodies for in vitro scientific and research use; biochemically labelled and enzyme labelled antibodies for use in science; microparticles containing fluorescent dyes for flow cytometry and scientific use; enzyme and chemical labelling molecules for use in science; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; assays and reagents for use in scientific, laboratory and research purposes; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; Chemical reagent for research purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules; Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for use in science; reagents in kit form for performing assays for scientific and research use; flow cytometry kits comprised of research reagents, buffers and controls for research laboratory use | ACTIVE | — |
| 005 | Fluorescent dyes and chemicals for medical use; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for medical purposes; proteins for medical use; cell culture proteins for medical use; monoclonal antibodies for medical use; monoclonal antibodies for in vitro medical use; fluorescent dyes for medical use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; biochemically labelled and enzyme labelled antibodies for medical use; microparticles containing fluorescent dyes for flow cytometry and medical use; chemical and biochemical preparations, assays, dyes, and reagents for clinical and medical laboratory use; chemical reagents for medical purposes for flow cytometry; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical purposes; Chemical reagent for medical purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules. chemicals and chemical reagents for medical use; reagents in kit form for performing assays for medical purposes; chemicals agents for use in separation for medical use; cell culture media for use in separation techniques for medical use; biochemical test kits comprising assays and reagents for medical purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for medical purposes; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for medical purposes; flow cytometry kits comprised of research reagents, buffers and controls for medical purposes | ACTIVE | — |
| 042 | Chemical analysis and research for others; medical laboratory services; medical testing for medical, scientific and research purposes; research and development services for others in the fields of nucleic acid, protein and antibody conjugation and modification; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bio-Rad Laboratories, Inc.
- Other trademarks owned by Bio-Rad Laboratories, Inc.
- Other trademarks owned by Bio-Rad Laboratories, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named STARBRIGHT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 6, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 6, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 13, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 12, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 12, 2025 | CNFR | SU - FINAL REFUSAL - WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 2, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2025 | ALIE | ASSIGNED TO LIE | — |
| Aug 26, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 29, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2025 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 26, 2025 | IUAF | USE AMENDMENT FILED | — |
| Jun 26, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 26, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 26, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 26, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 26, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 29, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 29, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 26, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 26, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 29, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 29, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 26, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 3, 2024 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jul 3, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jul 3, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 3, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 26, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 26, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 31, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 11, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 25, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 14, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 5, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 22, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 9, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2022 | NWAP | NEW APPLICATION ENTERED | — |